skip to main content
Idioma:
Tipo de recurso Mostra resultados com: Mostra resultados com: Índice

Potency of nano-antibacterial formulation from Sargassum binderi against selected human pathogenic bacteria

Moni, Sivakumar Sivagurunathan; Alam, Mohammad Firoz; Safhi, M M.; Jabeen, Aamena; Sanobar, Syeda; Siddiqui, Rahimullah; Moochikkal, Remesh

Brazilian Journal of Pharmaceutical Sciences; Vol. 54 No. 4 (2018); e17811

Universidade de São Paulo. Faculdade de Ciências Farmacêuticas 2018-12-20

Acesso online

  • Título:
    Potency of nano-antibacterial formulation from Sargassum binderi against selected human pathogenic bacteria
  • Autor: Moni, Sivakumar Sivagurunathan; Alam, Mohammad Firoz; Safhi, M M.; Jabeen, Aamena; Sanobar, Syeda; Siddiqui, Rahimullah; Moochikkal, Remesh
  • Assuntos: Red Sea; Sargassum Species; Fatty Acid Vesicles; Antibacterial Formulations
  • É parte de: Brazilian Journal of Pharmaceutical Sciences; Vol. 54 No. 4 (2018); e17811
  • Descrição: Seaweeds constitutes an abundant marine reserve that can be harnessed as source of new pharmaceutical agents. Sargassum binderi Sonder ex J. Agardh is a brown seaweed that is predominantly available from December to March in the Red Sea, Jazan, Kingdom of Saudi Arabia (KSA). In this study, three extracts were isolated using three different techniques, and were subjected to antibacterial assay. The petroleum ether extract of Sargassum binderi was more effective against selected human pathogenic bacteria than the other extracts. Therefore, further studies were focused on developing oleic acid vesicles entrapped with the petroleum ether extract of Sargassum binderi, with the aim of enhancing its penetration property. Oleic acid vesicles were prepared by entrapping petroleum ether extract of Sargassum binderi using film hydration technique. The formulated vesicles were in nanoscale, and so were termed phyto-nanovesicles (PNVs). The spectrum of antibacterial activity of PNVs showed that it is a promising formulation against S. aureus, S. pyogenes, B. subtilis, E. coli, K. pneumoniae and P. aeruginosa. The microbial sensitivities to the PNVs was in the order E.coli > B. subtilis > S. aureus > S. pyogenes > K. pneumoniae > P. aeruginosa. Thus, the PNV formulation possesses promising and effective antimicrobial potential against human pathogenic bacteria.
  • Títulos relacionados: https://www.revistas.usp.br/bjps/article/view/159301/154097
  • Editor: Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
  • Data de criação/publicação: 2018-12-20
  • Formato: Adobe PDF
  • Idioma: Inglês
Links
Voltar para lista de resultados

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.